Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lukens Medical -- Ignore unavailable to you. Want to Upgrade?

To: raydit who wrote (53)	12/31/1997 11:04:00 AM
From: David Rubin	Read Replies (1) \| Respond to of 55

You are probably right but on the surface it appears that the new CEO is taking charge and trying to grow the company. This might very well be a smoke-screen, but it still might be good for a quick run-up in the stock, even if short lived. The stock has already shown signs of recovery now that tax selling is over. Ignoring the charge, Luken's says they will post better than last year's $0.17 per share. This means the 1997 P/E will be less than 12.5. For those who believe in the new growth prospects, Luken's is a value play. Personally I still don't like the company much. But I may jump in for a short ride back to 3 and then wait for the dust to settle.